With an average user rating of 4.4★, the stroke risk category is one of the App Store's strongest. Browse all 177+ apps we track, sorted so the most loved ones surface first.
This medical app assists practitioners in predicting stroke, TIA, or embolism risk using CHA₂DS₂-VASc and CHADS₂ scores for patients with atrial fibrillation. It provides precise calculations to help determine necessary anticoagulant or antiplatelet therapy.
This app provides science-based cognitive, language, and speech therapy exercises for individuals recovering from neurological conditions like stroke, TBI, and aphasia. It offers personalized, AI-guided activities to improve memory, communication, attention, and more, accessible anytime and anywhere.
This medical app provides physicians with essential tools for acute stroke management. It includes calculators for NIHSS, ABCD2, CHA2DS2-VASc, and ASPECTS scores, along with guideline summaries for thrombolysis and thrombectomy. A time manager helps track critical door-to-needle times.
AF Stroke Risk tops our stroke risk apps ranking as of July 2026, with a 1.0-star average from 1 App Store ratings, and it's free to download.
Are there free stroke risk apps for iPhone?
Yes — 19 of the top stroke risk apps we rank are free to download, including AF Stroke Risk and Constant Therapy: Brain+Speech.
Does AF Stroke Risk have ads or in-app purchases?
AF Stroke Risk has no ads and has no in-app purchases, according to its App Store listing as of July 2026.
How many stroke risk apps are on the App Store?
We track 177+ stroke risk apps on the iOS App Store as of July 2026, ranked by rating, recency, and analysis of real user reviews.
What is AF Stroke Risk used for?
AF Stroke Risk is a medical app designed to help practitioners predict the risk of stroke, transient ischemic attack (TIA), or embolism in patients with atrial fibrillation using established clinical scores like CHA₂DS₂-VASc and CHADS₂.
What clinical scores does AF Stroke Risk utilize?
The app utilizes the CHA₂DS₂-VASc and CHADS₂ scores, which are clinical prediction rules used to estimate stroke risk in patients with non-rheumatic atrial fibrillation.